Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3

dc.contributor.authorFaber, Erika
dc.contributor.authorVan Schalkwyk, Antoinette
dc.contributor.authorTshilwane, Selaelo Ivy
dc.contributor.authorVan Kleef, Mirinda
dc.contributor.authorPretorius, Alri
dc.date.accessioned2024-01-10T08:44:03Z
dc.date.issued2024-01
dc.descriptionDATA AVAILABILITY : Data will be made available on request.en_US
dc.description.abstractThe viral proteins VP1-1, VP2, VP4, VP7 and NS3, of African horse sickness virus serotype 4 (AHSV4), have previously been identified to contain CD8+ T cell epitopes. In this study, overlapping peptides spanning the entire sequences of these AHSV4 proteins were synthesized and used to map epitopes. Peripheral blood mononuclear cells (PBMC) isolated from five horses immunized with an attenuated AHSV4 were stimulated in vitro with the synthesized peptides. Various memory immune assays were used to identify the individual peptides that contain CD8+ T cell epitopes, CD4+ T cell epitopes and linear B cell epitopes. The newly discovered individual peptides of AHSV4 proteins VP1-1, VP4, VP7 and/or NS3 that contain CD8+ T cell, CD4+ T cell or linear B cell epitopes could contribute to the design and development of new generation AHS peptide-based vaccines and therapeutics.en_US
dc.description.departmentVeterinary Tropical Diseasesen_US
dc.description.embargo2024-12-28
dc.description.librarianhj2023en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipThe Economic competitiveness support programme, ARC-OVR, South Africa.en_US
dc.description.urihttp://www.elsevier.com/locate/vaccineen_US
dc.identifier.citationFaber, E., Van Schalkwyk, A., Tshilwane, S.I. et al. 2024, 'Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3', Vaccine, vol. 42, no. 2, pp. 136-145, doi : 10.1016/j.vaccine.2023.12.028.en_US
dc.identifier.issn0264-410X (print)
dc.identifier.issn1873-2518 (online)
dc.identifier.other10.1016/j.vaccine.2023.12.028
dc.identifier.urihttp://hdl.handle.net/2263/93888
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rights© 2023 Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Vaccine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Vaccine, vol. 42, no. 2, pp. 136-145, 2024, doi : 10.1016/j.vaccine.2023.12.028.en_US
dc.subjectOverlapping synthetic peptidesen_US
dc.subjectT cell epitopesen_US
dc.subjectLinear B cell epitopesen_US
dc.subjectNew generation AHS peptide-based vaccinesen_US
dc.subjectConserved epitopesen_US
dc.subjectPeripheral blood mononuclear cells (PBMC)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleIdentification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3en_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
Faber_Identification_2024.pdf
Size:
2 MB
Format:
Adobe Portable Document Format
Description:
Postprint Article
Loading...
Thumbnail Image
Name:
Faber_IdentificationSupplA_2024.pdf
Size:
500.97 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Material A
Loading...
Thumbnail Image
Name:
Faber_IdentificationSupplB_2024.xlsx
Size:
5.91 MB
Format:
Microsoft Excel XML
Description:
Supplementary Material B

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: